Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has actually axed its once-monthly dual GLP-1/ GIP receptor agonist, ending (PDF) prog...

Daiichi pays out Merck $170M to develop lung cancer cells T-cell engager pact

.Merck &amp Co. has rapidly gotten back a number of the prices of its own Weapon Therapeutics purcha...

BioMarin halts preclinical gene treatment for heart condition

.After BioMarin carried out a springtime clean of its pipe in April, the business has actually deter...

Eisai plants molecular adhesive SEED along with $1.5 B biobucks handle

.Significant Pharmas stay stuck to the tip of molecular adhesive degraders. The most recent company ...

Life scientific research credit rating agency reveals along with $600M

.A brand new international lifestyle scientific research credit history firm, termed Symbiotic Capit...

BMS ditches TIGIT, leaving $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing yet another big bet from the Caforio time, canceling an offer for Age...

Nuvation halts wager inhibitor after considering stage 1 information

.After taking a look at period 1 information, Nuvation Bio has actually decided to halt work on its ...

' Clinical intuition' led FDA experts to support Zevra's rare condition med

.Zevra Therapeutics' rare disease drug appears to be on the course to approval this autumn after gai...

Pfizer takes $230M reached after axing fell short DMD gene therapy

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) gene treatment failure has blown a $230 thousand ...

AC Immune finds 'spots' possible in Alzheimer's drug information

.After much more than twenty years of work with neurodegenerative diseases, Swiss biotech AC Invulne...